Skip to main content

Table 1 Descriptive Characteristics of Study Participants

From: Suppressor of cytokine signaling 3 (SOCS3) is not an independent biomarker of colorectal adenoma risk

Variable Case (n = 93) Control (n = 229) p-value *
Age median (1st, 3rd quartile)** 58 (51, 56) 55 (50, 63) 0.03
Race-White N (%)† 73 (78) 177 (77) 0.88
Sex-Male N (%) 51 (55) 85 (37) 0.004
WHR median (1st, 3rd quartile) 0.922 (0.854, 1.000) 0.888 (0.804, 979) 0.04
Family History of CRC - N (%) 16 (20) 31 (15) 0.37
Plasma IL-6 median (1st, 3rd quartile) 0.21 (0.00, 0.56) 0.07 (0.00, 0.41) 0.01
Plasma TNFα median (1st, 3rd quartile) 1.93 (1.44, 2.74) 1.75 (1.30, 2.44) 0.14
Plasma CRP median (1st, 3rd quartile) 3,959 (1,934, 14,278) 7,239 (2,294, 16,728) 0.14
Tissue SOCS3 median (1st, 3rd quartile) 3.09 (2.33, 3.77) 3.09 (2.35, 3.80) 0.77
  1. * P-values are from Fishers Exact Test for categorical variables and Mann-Whitney test to compare medians for continuous variables.
  2. ** Standard error (se); Waist Hip Ratio (WHR); Suppressor of Cytokine Signaling 3 (SOCS3)
  3. † Percentages within columns